Literature DB >> 33161483

Cross-sectional validation of the PROMIS-Preference scoring system by its association with social determinants of health.

Janel Hanmer1.   

Abstract

PURPOSE: PROMIS-Preference (PROPr) is a generic, societal, preference-based summary score that uses seven domains from the Patient-Reported Outcomes Measurement Information System (PROMIS). This report evaluates construct validity of PROPr by its association with social determinants of health (SDoH).
METHODS: An online panel survey of the US adult population included PROPr, SDoH, demographics, chronic conditions, and four other scores: the EuroQol-5D-5L (EQ-5D-5L), Health Utilities Index (HUI) Mark 2 and Mark 3, and the Short Form-6D (SF-6D). Each score was regressed on age, gender, health conditions, and a single SDoH. The SDoH coefficient represents the strength of its association to PROPr and was used to assess known-groups validity. Convergent validity was evaluated using Pearson correlations between different summary scores and Spearman correlations between SDoH coefficients from different summary scores.
RESULTS: From 4142 participants, all summary scores had statistically significant differences for variables related to education, income, food and financial insecurity, and social interactions. Of the 42 SDoH variables tested, the number of statistically significant variables was 27 for EQ-5D-5L, 17 for HUI Mark 2, 23 for HUI Mark 3, 27 for PROPr, and 27 for SF-6D. The average SDoH coefficients were - 0.086 for EQ-5D-5L, - 0.039 for HUI Mark 2, - 0.063 for HUI Mark 3, - 0.064 for PROPr, and - 0.037 for SF-6D. Despite the difference in magnitude across the measures, Pearson correlations were 0.60 to 0.76 and Spearman correlations were 0.74 to 0.87.
CONCLUSIONS: These results provide evidence of construct validity supporting the use of PROPr monitor population health in the general US population.

Entities:  

Keywords:  Health-related quality of life; PROMIS-Preference (PROPr); Patient-Reported Outcomes Measurement Information System (PROMIS); Social determinants of health

Mesh:

Year:  2020        PMID: 33161483      PMCID: PMC7954821          DOI: 10.1007/s11136-020-02691-3

Source DB:  PubMed          Journal:  Qual Life Res        ISSN: 0962-9343            Impact factor:   4.147


  18 in total

1.  Regression-based sampling for persons with high health expenditures: evaluating accuracy and yield with the 1997 MEPS.

Authors:  John F Moeller; Steven B Cohen; Nancy A Mathiowetz; Lap-Ming Wun
Journal:  Med Care       Date:  2003-07       Impact factor: 2.983

Review 2.  Measurement of health state utilities for economic appraisal.

Authors:  G W Torrance
Journal:  J Health Econ       Date:  1986-03       Impact factor: 3.883

3.  Health measurement in the third era of health.

Authors:  Lester Breslow
Journal:  Am J Public Health       Date:  2005-12-01       Impact factor: 9.308

4.  Psychosocial and neighborhood correlates of health-related quality of life: A multi-level study among Hispanic adults.

Authors:  Sarah D Mills; Rina S Fox; Sandy Bohan; Scott C Roesch; Georgia Robins Sadler; Vanessa L Malcarne
Journal:  Cultur Divers Ethnic Minor Psychol       Date:  2019-04-01

5.  Perceived discrimination and health-related quality-of-life: gender differences among older African Americans.

Authors:  Sheryl L Coley; Carlos F Mendes de Leon; Earlise C Ward; Lisa L Barnes; Kimberly A Skarupski; Elizabeth A Jacobs
Journal:  Qual Life Res       Date:  2017-07-25       Impact factor: 4.147

6.  Erratum to: Interpersonal discrimination and health-related quality of life among black and white men and women in the United States.

Authors:  Sherrill L Sellers; Dasha Cherepanov; Janel Hanmer; Dennis G Fryback; Mari Palta
Journal:  Qual Life Res       Date:  2013-08       Impact factor: 4.147

7.  Neighborhood Socioeconomic Status and Trajectories of Physical Health-Related Quality of Life Among Stroke Survivors.

Authors:  Erica Twardzik; Philippa Clarke; Michael R Elliott; William E Haley; Suzanne Judd; Natalie Colabianchi
Journal:  Stroke       Date:  2019-09-17       Impact factor: 7.914

8.  Gender differences in health-related quality-of-life are partly explained by sociodemographic and socioeconomic variation between adult men and women in the US: evidence from four US nationally representative data sets.

Authors:  Dasha Cherepanov; Mari Palta; Dennis G Fryback; Stephanie A Robert
Journal:  Qual Life Res       Date:  2010-05-23       Impact factor: 4.147

9.  The Medicare Health Outcomes Survey program: overview, context, and near-term prospects.

Authors:  Nathaniel Jones; Stephanie L Jones; Nancy A Miller
Journal:  Health Qual Life Outcomes       Date:  2004-07-12       Impact factor: 3.186

10.  A systematic review and meta-analysis of the prevalence of common mental disorders in people with non-communicable diseases in Bangladesh, India, and Pakistan.

Authors:  Eleonora P Uphoff; Louise Newbould; Ian Walker; Nabila Ashraf; Santosh Chaturvedi; Arun Kandasamy; Papiya Mazumdar; Nick Meader; Aliya Naheed; Rusham Rana; Jerome Wright; Judy M Wright; Najma Siddiqi; Rachel Churchill
Journal:  J Glob Health       Date:  2019-12       Impact factor: 4.413

View more
  3 in total

1.  Health-related quality of life and social determinants of health following COVID-19 infection in a predominantly Latino population.

Authors:  Kathleen R Case; Chen-Pin Wang; Meredith G Hosek; Sarah F Lill; Alexandra B Howell; Barbara S Taylor; James Bridges; Daniel J MacCarthy; Paula Winkler; Joel Tsevat
Journal:  J Patient Rep Outcomes       Date:  2022-06-23

Review 2.  Evidence on the relationship between PROMIS-29 and EQ-5D: a literature review.

Authors:  Tianxin Pan; Brendan Mulhern; Rosalie Viney; Richard Norman; An Tran-Duy; Janel Hanmer; Nancy Devlin
Journal:  Qual Life Res       Date:  2021-06-28       Impact factor: 4.147

3.  A Comparison of PROPr and EQ-5D-5L Value Sets.

Authors:  Tianxin Pan; Brendan Mulhern; Rosalie Viney; Richard Norman; Janel Hanmer; Nancy Devlin
Journal:  Pharmacoeconomics       Date:  2021-11-17       Impact factor: 4.981

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.